These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 39116495)
1. Huanglian Jiedu Decoction enhances the stability of atherosclerotic plaques through SLC2A1-mediated efferocytosis. Zhou G; Lin L; Wang S; Dong M; Lu K; Zhang Y; Lin Z; Lin J; Wu W; Peng R; Luo C Int Immunopharmacol; 2024 Oct; 140():112834. PubMed ID: 39116495 [TBL] [Abstract][Full Text] [Related]
2. Huanglian Jiedu decoction inhibits vascular smooth muscle cell-derived foam cell formation by activating autophagy via suppressing P2RY12. Lin J; Gu M; Wang X; Chen Y; Chau NV; Li J; Chu Q; Qing L; Wu W J Ethnopharmacol; 2024 Jun; 328():118125. PubMed ID: 38561055 [TBL] [Abstract][Full Text] [Related]
3. Metabolomics and lipidomics combined with serum pharmacochemistry uncover the potential mechanism of Huang-Lian-Jie-Du decoction alleviates atherosclerosis in ApoE Yang X; Chi C; Li W; Zhang Y; Yang S; Xu R; Liu R J Ethnopharmacol; 2024 Apr; 324():117748. PubMed ID: 38216103 [TBL] [Abstract][Full Text] [Related]
4. Huang-Lian-Jie-Du Decoction Attenuates Atherosclerosis and Increases Plaque Stability in High-Fat Diet-Induced ApoE Cai Y; Wen J; Ma S; Mai Z; Zhan Q; Wang Y; Zhang Y; Chen H; Li H; Wu W; Li R; Luo C Front Physiol; 2021; 12():666449. PubMed ID: 34539422 [TBL] [Abstract][Full Text] [Related]
5. Transcriptomic analysis reveals the critical role of chemokine signaling in the anti-atherosclerosis effect of Xuefu Zhuyu decoction. Jia D; Zhao M; Zhang X; Cheng X; Wei Q; Lou L; Zhao Y; Jin Q; Chen M; Zhang D J Ethnopharmacol; 2024 Oct; 332():118245. PubMed ID: 38679399 [TBL] [Abstract][Full Text] [Related]
6. Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of Huanglian Jiedu Decoction in Treating Atherosclerosis. Liang J; Huang Y; Mai Z; Zhan Q; Lin H; Xie Y; Wang H; Liu Y; Luo C Drug Des Devel Ther; 2021; 15():1779-1795. PubMed ID: 33958856 [TBL] [Abstract][Full Text] [Related]
7. [Huanglian jiedu decoction regulated and controlled differentiation of monocytes, macrophages, and foam cells: an experimental study]. Li T; Han JY; Wang BB; Chen B; Li YM; Yu ZJ; Xue X; Zhang JP; Wang XB; Zeng H; Ma YL Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Sep; 34(9):1096-102. PubMed ID: 25335334 [TBL] [Abstract][Full Text] [Related]
8. Quercetin Attenuates KLF4-Mediated Phenotypic Switch of VSMCs to Macrophage-like Cells in Atherosclerosis: A Critical Role for the JAK2/STAT3 Pathway. Xiang L; Wang Y; Liu S; Ying L; Zhang K; Liang N; Li H; Luo G; Xiao L Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062998 [TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes. Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260 [TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of Huanglian Jiedu decoction in treating Alzheimer's disease by regulating microbiome Zheng R; Shi S; Zhang Q; Yuan S; Guo T; Guo J; Jiang P Front Cell Infect Microbiol; 2023; 13():1140945. PubMed ID: 37009506 [TBL] [Abstract][Full Text] [Related]
11. ZeXieYin formula alleviates atherosclerosis by inhibiting the MAPK/NF-κB signaling pathway in APOE-/- mice to attenuate vascular inflammation and increase plaque stability. Huang R; Sun Y; Liu R; Zhu B; Zhang H; Wu H J Ethnopharmacol; 2024 Jun; 327():117969. PubMed ID: 38437888 [TBL] [Abstract][Full Text] [Related]
12. Gualou-Xiebai herb pair and its active ingredients act against atherosclerosis by suppressing VSMC-derived foam cell formation via regulating P2RY12-mediated lipophagy. Bao Y; Zhu L; Wang Y; Liu J; Liu Z; Li Z; Zhou A; Wu H Phytomedicine; 2024 Jun; 128():155341. PubMed ID: 38518636 [TBL] [Abstract][Full Text] [Related]
13. Reduction of TMAO level enhances the stability of carotid atherosclerotic plaque through promoting macrophage M2 polarization and efferocytosis. Shi W; Huang Y; Yang Z; Zhu L; Yu B Biosci Rep; 2021 May; 41(6):. PubMed ID: 33969376 [TBL] [Abstract][Full Text] [Related]
14. Huanglian-Jiedu decoction promotes adipose thermogenesis in obese mice by suppressing the expression of HDAC3. Xu P; Zhu Z; Zhou R; Wei Y; Xu F; Shen L; Wang Z; Xue Y; Yu X; Zhao J; Yan J; Jin Y; Fang P; Shang W J Ethnopharmacol; 2025 Jan; 336():118760. PubMed ID: 39216772 [TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanism of the Effect of Huanglian Jiedu Decoction on Type 2 Diabetes Mellitus Based on Network Pharmacology and Molecular Docking. Yin B; Bi YM; Fan GJ; Xia YQ J Diabetes Res; 2020; 2020():5273914. PubMed ID: 33134394 [TBL] [Abstract][Full Text] [Related]
16. Macrophage ALDH2 (Aldehyde Dehydrogenase 2) Stabilizing Rac2 Is Required for Efferocytosis Internalization and Reduction of Atherosclerosis Development. Zhang J; Zhao X; Guo Y; Liu Z; Wei S; Yuan Q; Shang H; Sang W; Cui S; Xu T; Yang K; Guo J; Pan C; Wang J; Pang J; Han T; Chen Y; Xu F Arterioscler Thromb Vasc Biol; 2022 Jun; 42(6):700-716. PubMed ID: 35354308 [TBL] [Abstract][Full Text] [Related]
17. Systems pharmacology, proteomics and in vivo studies identification of mechanisms of cerebral ischemia injury amelioration by Huanglian Jiedu Decoction. Shang J; Li Q; Jiang T; Bi L; Lu Y; Jiao J; Song Q; Yan M; Shabuerjiang L; Wang J; Liu X J Ethnopharmacol; 2022 Jul; 293():115244. PubMed ID: 35378193 [TBL] [Abstract][Full Text] [Related]
18. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1. Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R Cardiovasc Pathol; 2018; 33():6-15. PubMed ID: 29268138 [TBL] [Abstract][Full Text] [Related]
19. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling. Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543 [TBL] [Abstract][Full Text] [Related]
20. Non-Lethal Sonodynamic Therapy Inhibits Atherosclerotic Plaque Progression in ApoE-/- Mice and Attenuates ox-LDL-mediated Macrophage Impairment by Inducing Heme Oxygenase-1. Wang Y; Wang W; Xu H; Sun Y; Sun J; Jiang Y; Yao J; Tian Y Cell Physiol Biochem; 2017; 41(6):2432-2446. PubMed ID: 28468003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]